openPR Logo
Press release

Colorectal Procedures Market is anticipated to grow further till USD 42.8 Billion by 2031

12-20-2023 06:30 PM CET | Health & Medicine

Press release from: Global Insight Services

Colorectal Procedures Market is anticipated to grow further

Global Colorectal Procedures Market was valued at USD 12.4 Billion in 2021 and it is anticipated to grow further till USD 42.8 Billion by 2031, at a CAGR of 13.2% during the forecast period.

The global colorectal procedures market report from Global Insight Services is the single authoritative source of intelligence on Colorectal Procedures Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.

Read more about Colorectal Procedures Market here: https://www.globalinsightservices.com/reports/colorectal-procedure-market/?utm_source=sidram&utm_medium=openpr&utm_campaign=20122023

A colorectal procedure is an operation that involves colon resection and anastomosis and is used to treat a variety of diseases, including diverticulitis, ulcerative colitis, Crohn's disease, mechanical blockage, and more. The technique helps remove the colon in its entirety or in part. Additionally removed are nearby lymph nodes. Hemicolectomies, partial colectomies, and segmental resections are terms used to describe the removal of only a portion of the colon. The surgeon cuts out the cancerous portion of the colon and a tiny section of healthy colon on either side. Compared to other general surgical subspecialties, colorectal surgery has a higher risk of morbidity and mortality. All-cause mortality rates following colorectal surgery range from 1% to 16.4%, and morbidity rates can reach 35%, according to the National Library of Medicine

Request free sample copy of this research study: https://www.globalinsightservices.com/request-sample/GIS10416/?utm_source=sidram&utm_medium=openpr&utm_campaign=20122023

Market Trends and Drivers

One of the most prevalent and deadly tumours that develops in people as a result of the interaction of genetic and environmental factors is colorectal cancer. The World Health Organization (WHO) estimates that there will be 1.93 million new cases of colorectal cancer worldwide in 2020, making it the third most common type of cancer. In addition, colorectal cancer caused 916 000 deaths in 2020, with mortality and incidence rates differing globally. It ranks second among cancers in women and third among cancers in males. About 1 in 23 men and 1 in 25 women will acquire colorectal cancer in their lifetime. The second most prevalent disease to cause mortality and the third most common cancer overall is colorectal cancer.

Get Customized Report as Per Your Requirement: https://www.globalinsightservices.com/request-customization/GIS10416/?utm_source=sidram&utm_medium=openpr&utm_campaign=20122023

By Product

-Endoscope
-Electrosurgery
-Handheld Device and Visual Systems
-Sealing & Stapling Devices
-Ligation Clips, Dilators, & Speculas
-Cutter & Shears
-Accessories
-Others

By Surgery Type

-Right Hemicolectomy
-Left Hemicolectomy
-Subtotal Colectomy
-Low Anterior Resection
-Abdomino-Perineal Resection
-Others

By End User

-Hospitals & Clinics
-Surgery Centers
-Others

By Indication

-Colon Polyps
-Crohn's Disease
-Colorectal Cancer
-Colitis
-Irritable Bowel Syndrome
-Others

Major Players in the Global Colorectal Procedures Market
The key players covered in the report are Ethicon (Johnson & Johnson Services, Inc.); Medtronic; Colospan Ltd; SAFEHEAL; B. Braun Melsungen AG; Cardinal Health Inc; Boston Scientific Corporation; CooperSurgical, Inc.; Olympus Corporation; and Suturion AB among others.

Purchase your copy now: https://www.globalinsightservices.com/checkout/single_user/GIS10416/?utm_source=sidram&utm_medium=openpr&utm_campaign=20122023

With Global Insight Services, you receive:

- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Colorectal Procedures Market is anticipated to grow further till USD 42.8 Billion by 2031 here

News-ID: 3334286 • Views:

More Releases from Global Insight Services

Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing at 17.5% CAGR | Overall Study Report
Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing …
The Immuno Oncology Drugs Market is rapidly emerging as a transformative segment in the global healthcare industry. These drugs harness the body's immune system to identify and attack cancer cells, offering innovative treatment alternatives to traditional chemotherapy and radiation therapies. Immuno-oncology therapies include monoclonal antibodies, checkpoint inhibitors, cancer vaccines, and cell-based therapies such as CAR-T cells. The growth of this market is primarily driven by advancements in biotechnology, an improved
GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Overall Study Report
GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Ove …
The GLP 1 Market is experiencing unprecedented growth, fueled by the rising prevalence of type 2 diabetes and obesity globally. GLP-1, or glucagon-like peptide-1 receptor agonists, represents a groundbreaking therapeutic class that improves insulin secretion, reduces glucagon production, and slows gastric emptying. These mechanisms not only enhance glycemic control but also support weight management, making GLP-1 therapies a preferred choice among healthcare providers and patients alike. Over the years, the
Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAGR | Key Players: EasyMile, Navya, Aurrigo
Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAG …
Market Overview Autonomous Bus Market is revolutionizing the future of urban mobility through advanced automation technologies. Valued at $2.1 billion in 2024, the market is projected to reach $11.6 billion by 2034, expanding at a strong CAGR of 18.8%. This market focuses on the development and deployment of self-driving buses equipped with cutting-edge sensors, artificial intelligence, and vehicle-to-everything (V2X) communication systems. These buses are designed to improve road safety, enhance passenger
Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | Key Players: Apollo Tyres, Nokian Tyres, Hankook Tire
Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | …
Market Overview Automotive Tire Market is experiencing remarkable growth as the industry embraces innovation, sustainability, and digital transformation. Valued at $406 billion in 2024, the market is projected to soar to $976.7 billion by 2034, reflecting a CAGR of 9.2%. This expansion is primarily driven by the surge in global vehicle production, growing consumer preference for durable and high-performance tires, and the increasing adoption of smart tire technologies. The Automotive Tire

All 5 Releases


More Releases for Colorectal

Metastatic Colorectal Cancer Therapeutics Market - Innovation in Motion: Elevate …
Newark, New Castle, USA: The "Metastatic Colorectal Cancer Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Metastatic Colorectal Cancer Therapeutics Market: https://www.growthplusreports.com/report/metastatic-colorectal-cancer-therapeutics-market/8685 This latest report researches the
Potential Opportunities of Colorectal Cancer Therapeutics Market
The global colorectal cancer therapeutics market size is projected to reach USD 16.58 billion by 2026, owing to the rise in the prevalence of colorectal cancer worldwide. A report by Fortune Business Insights(TM) titled, "Colorectal Cancer Therapeutics Market Size, Share & Industry Analysis, By Therapy (Targeted Therapy, Immunotherapy, Chemotherapy, Others), By Cancer Type (Colorectal Adenocarcinoma, Gastrointestinal Carcinoid Tumors, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and
Colorectal Cancer Pipeline Therapeutic Review H1 2017
Colorectal Cancer Pipeline Review H1 2017 provides an overview of the Colorectal Cancer (Oncology) pipeline landscape. Colorectal cancer is cancer that starts in the large intestine (Colorectal). There is no single cause of colorectal cancer. Nearly all colorectal cancers begin as noncancerous (benign) polyps, which slowly develop into cancer. For More on Colorectal Cancer Pipeline Review H1 2017 Report Inquire @ https://goo.gl/1HQ4Fn . Report Description: Pharmaceutical guide Colorectal Cancer - Pipeline Review H1
US Colorectal Cancer Drug Pipeline Analysis
Among all the regions affected with colorectal cancer, the US would continue to account for a giant’s share owing to its huge population base. With regards to rates of increase, it is most likely that the US would witness a modest increase in the prevalence of the disease, mostly as a result of the country having already reached epidemic proportions of the disease. According to estimates, approximately 55,000 people die
Colorectal Cancer - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Colorectal Cancer - Heat Map and Analysis to its growing collection of premium market research reports. Colorectal cancer (CRC), otherwise known as bowel cancer, is a malignancy originating in the colon (the large intestine) or rectum, both of which are located towards the end of the human gastrointestinal tract. It begins as a benign tumor, which is almost always in
Colorectal Cancer Treatment Market- Global Outlook 2024
Colorectal cancer is cancer that starts in the colon or rectum. The colon and the rectum are parts of the large intestine, which is the lower part of the body’s digestive system. The colon absorbs water and nutrients from the food and stores waste matter (stool). Stool moves from the colon into the rectum before it leaves the body. Colorectal cancer often begins as a growth called a polyp, which